Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1145
-
Total 13F shares, excl. options
-
91.8M
-
Shares change
-
-740K
-
Total reported value, excl. options
-
$66B
-
Value change
-
-$554M
-
Put/Call ratio
-
1.15
-
Number of buys
-
461
-
Number of sells
-
-565
-
Price
-
$718.54
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2023
1,324 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2023.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.8M shares
of 105M outstanding shares and own 87.43% of the company stock.
Largest 10 shareholders include FMR LLC (9.17M shares), BlackRock Inc. (9.09M shares), VANGUARD GROUP INC (8.86M shares), JPMORGAN CHASE & CO (6.54M shares), Capital World Investors (5.55M shares), STATE STREET CORP (4.99M shares), Capital International Investors (2.96M shares), Dodge & Cox (2.39M shares), GEODE CAPITAL MANAGEMENT, LLC (2.28M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.25M shares).
This table shows the top 1145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.